February 11, 2025 · Form 4 insider transaction
Gordon Murdo sold 8,771 shares of Amgen Inc. at $294.79 per share, a transaction worth $2.59M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.
The price reported is an average price. The prices ranged from $294.6101 to $294.885 per share. Full information regarding the number of shares purchased at each separate price within the range set forth is available upon request by the SEC staff, the issuer or a security holder of the issuer.; These shares include 773 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.